Caris Life Sciences Inc
(CAI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2006 | 12-2005 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 20,359 | N/A |
| Receivables | 31,920 | N/A |
| Income taxes - deferred | 915 | N/A |
| Other current assets | 3,356 | 0 |
| TOTAL | $59,519 | $N/A |
| Non-Current Assets | ||
| PPE Net | 161,812 | N/A |
| Investments And Advances | 4,329 | 0 |
| Intangibles | 57,340 | 0 |
| TOTAL | $223,481 | $N/A |
| Total Assets | $283,000 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 5,000 | N/A |
| Accounts payable and accrued liabilities | 56,023 | 0 |
| Accrued Expenses | 15,276 | N/A |
| TOTAL | $77,564 | $N/A |
| Non-Current Liabilities | ||
| Long Term Debt | 110,750 | N/A |
| Deferred Revenues | 740 | N/A |
| Other Non-Current Liabilities | 37,500 | 0 |
| TOTAL | $172,781 | $N/A |
| Total Liabilities | $250,345 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 1,260 | N/A |
| Retained earnings | 26,400 | N/A |
| Other shareholders' equity | 4,995 | 0 |
| TOTAL | $32,655 | $N/A |
| Total Liabilities And Equity | $283,000 | $0 |